Clinical Trial Update: N-acetylcysteine for Tobacco Smoking [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating N-acetylcysteine for tobacco use disorder is reported, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Universidade Estadual de Londrina | Conditions: Tobacco Smoking, Oxidative Stress | Phase 3 | Status: UNKNOWN